Evoke Pharma Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
16.9 M |
Public Float |
12.94 M |
Evoke Pharma Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.44 |
Market Cap |
$15.94 M |
Shares Outstanding |
23.26 M |
Public Float |
14.35 M |
Address |
420 Stevens Avenue Solana Beach California 92075 United States |
Employees | - |
Website | http://www.evokepharma.com |
Updated | 07/08/2019 |
Evoke Pharma, Inc. is a pharmaceutical company, which engages in the development of drugs for the treatment of gastrointestinal disorders and diseases. It develops Gimoti, with promotility and anti-emetic effects, for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women with diabetes mellitus. The company was founded by Matthew J. |